Potentum Partners Logo
  • About
    • Our Mission
    • Our Team
    • Investment Strategy
    • ESG
    • Our Partner Managers
  • Global Leaders Program
  • Portfolio
    • Funds
    • Co-Investments
  • SMA Mandates
  • Press
  • Contact

Boston mRNA startup raises millions to test its targeted cancer therapies

by mardi-lowe | Nov 28, 2022 | Boston Globe Media

When Jacob Becraft addressed a bustling party of a hundred-plus employees, friends, and investors at his startup’s lab last month, he credited messenger RNA for bringing everyone back together in one room.

Recent Posts

  • Potentum Partners locks in $300m for global PE fund, preps successors
  • Rise Broadband Announces Acquisition by GI Partners
  • Why private equity could be super’s next big opportunity
  • Boston mRNA startup raises millions to test its targeted cancer therapies
  • Private equity heads for a ‘slow motion train wreck’

Recent Comments

No comments to show.

Potentum Partners

Our Mission

Our Team

Our Strategy

Our Partner Managers

Company Press

Investment

Global Leaders Program

Funds Portfolio

Co-Investment Portfolio

SMA Mandates

Responsible Investing

Melbourne

Suite 1920, Como Centre
644 Chapel St, South Yarra
Melbourne, VIC 3141

United States

525 Washington Blvd,
Suite 300, NJ 07310
United States

Pri Principles for Responsible Investment
Climate Active Network Member

Privacy Policy | Terms of Use
The information on this website is for general information purposes only. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. No material contained within this website should be construed or relied upon as providing recommendations in relation to any legal or financial product.